Search results for "Foveal thickness"

showing 5 items of 5 documents

Optical coherence tomography of macular thickness after biaxial vs coaxial microincision clear corneal cataract surgery

2009

PURPOSE To evaluate macular thickness changes after biaxial microincision versus coaxial small incision cataract surgery using optical coherence tomography (OCT). METHODS This prospective, randomized, marked study comprised 70 patients (70 eyes) undergoing biaxial microincision surgery or conventional coaxial phacoemulsification. Patients were evaluated by Stratus OCT preoperatively and 1 day, 4 weeks, and 8 weeks postoperatively. Best-corrected visual acuity (BCVA), phacoemulsification power, and effective phacoemulsification time (EPT) were evaluated. RESULTS In the biaxial group, median foveal thickness changed from 160 microm preoperatively to 168 microm 8 weeks postoperatively (p=0.018…

AdultMaleMicrosurgerymedicine.medical_specialtyVisual acuitygenetic structuresmedicine.medical_treatmentVisual AcuityFoveal thicknessMacular EdemaCornea03 medical and health sciencesPostoperative Complications0302 clinical medicineOptical coherence tomographyOphthalmologyBlood-Retinal BarrierHumansMedicineMacula LuteaProspective StudiesIntraoperative ComplicationsAgedAged 80 and overPhacoemulsificationmedicine.diagnostic_testbusiness.industrySignificant differenceGeneral MedicinePhacoemulsificationMiddle AgedCataract surgeryeye diseasesOphthalmologySmall incision030221 ophthalmology & optometryFemalesense organsmedicine.symptomCoaxialbusinessTomography Optical Coherence030217 neurology & neurosurgeryEuropean Journal of Ophthalmology
researchProduct

Retinal Imaging through Phakic Iris-Claw IOL.

2014

AbstractBackground: Phakic anterior chamber iris-fixated IOL (PIOL) are established for the correction of high myopia. These patients require attention to macular pathologies. This study was to evaluate the quality of imaging through the PIOLs. Methods: 54 eyes of 31 myopic and hyperopic patients with Verisyse®, Verisyse toric®, and Veriflex® phakic iris-fixated IOL were included. Mean preoperative refraction was −11.0 D and +5.7 D, respectively; mean follow-up time was 7.4 years (5–11 years). A matched control group was formed without PIOL implantation. OCT scans were performed and evaluated qualitatively and quantitatively. Results: In 52 eyes of 31 patients (96%), a 3D-OCT image and fund…

AdultMalemedicine.medical_specialtyPhakic Intraocular Lensesgenetic structuresAnterior ChamberVisual AcuityIrisFoveal thicknessFundus (eye)Refraction OcularRetinaImaging Three-DimensionalLens Implantation IntraocularOphthalmologymedicineMyopiaHumansPhakic iolIris clawmedicine.diagnostic_testbusiness.industrySignificant differenceFundus photographyHigh myopiaGeneral MedicineMiddle Agedeye diseasesOphthalmologyHyperopiaRetinal imagingFemalesense organsbusinessTomography Optical CoherenceFollow-Up StudiesSeminars in ophthalmology
researchProduct

Management of macular edema due to branch retinal vein occlusion with intravitreal injections of pegaptanib sodium

2009

Purpose To evaluate the efficacy of Pegaptanib Sodium as single therapy for macular edema due to non-ischemic branch retinal vein occlusion. Methods In this uncontrolled prospective pilot study 17 patients have been included with non-ischemic branch retinal vein occlusion. All of them showed macular edema in the OCT with central foveal thickness higher than 350 microns (mean, 541 +/- 140) and decrease in visual acuity lower than 0,5 Snellen ETDRS charts notation (mean, 0,16+/-0,14). After an initial injection of Pegaptanib Sodium evaluations were programmed every 5 weeks and further retreatments were developed in cases with macular thickness higher than 300 microns. No other therapies were …

medicine.medical_specialtyVisual acuitygenetic structuresbusiness.industryFoveal thicknessGeneral Medicinemedicine.diseaseeye diseasesSurgeryOphthalmologyPegaptanib SodiumMedicineBranch retinal vein occlusionsense organsmedicine.symptombusinessMacular edemaActa Ophthalmologica
researchProduct

Association of Birth Weight With Foveolar Thickness in Adulthood: Results From a Population-Based Study

2021

Purpose Low birth weight (BW) is associated with alterations of foveal shape development in childhood—leading to an increased retinal thickness of the fovea. The aim of the present study was to assess whether BW has a long-term effect on foveal retinal thickness (RT) and is still present in adulthood. Methods In the German population-based Gutenberg Health Study (GHS), participants were examined with spectral-domain optical coherence tomography. The association between self-reported BW and RT in the foveolar and perifoveal locations was assessed. Multivariable linear regression analyses with adjustment for potential confounders and grading of foveal hypoplasia were performed. Results Overal…

AdultMaleFovea Centralismedicine.medical_specialtyanatomyBirth weightVisual AcuityRetinachemistry.chemical_compoundFovealOphthalmologyHumansMedicinemaculaEye AbnormalitiesProspective StudiesAgedAged 80 and overbusiness.industryConfoundingbirth weightRetinalMiddle Agedmedicine.diseaseConfidence intervalHypoplasiafoveal thicknessLow birth weightFoveolar cellchemistrypopulation-based studyepidemiologyFemalemedicine.symptombusinessTomography Optical CoherenceFollow-Up StudiesInvestigative Opthalmology & Visual Science
researchProduct

Intravitreal ranibizumab treatment of retinal angiomatous proliferation

2010

. Purpose:  To determine the efficacy of intravitreal injections of ranibizumab in the treatment of retinal angiomatous proliferation (RAP) in neovascular age-related macular degeneration. Methods:  Retrospective, consecutive case series of 26 eyes (26 patients) treated with intravitreal injections of 0.5 mg ranibizumab for RAP. Patients received intravitreal injections at monthly intervals during upload phase for a 3-month period. Results:  Mean visual acuity before treatment was 0.75 ± 0.38logMAR (mean ± SD, n = 26). In the upload phase, mean visual acuity improved 4 weeks after the initial injection to 0.6 ± 0.37logMAR (n = 26) and to 0.53 ± 0.34logMAR (n = 26) 4 weeks after the third mo…

MaleAngiomatosismedicine.medical_specialtyVisual acuitygenetic structuresVisual AcuityAngiogenesis InhibitorsFoveal thicknessRetinal NeovascularizationAntibodies Monoclonal Humanizedchemistry.chemical_compoundOpticsRanibizumabOphthalmologymedicineHumansMaintenance phaseAgedRetrospective StudiesAged 80 and overbusiness.industryRetinalGeneral MedicineMiddle AgedMacular degenerationmedicine.diseaseeye diseasesOphthalmologyTreatment OutcomechemistryIntravitreal InjectionsRetreatmentWet Macular DegenerationFemalesense organsRanibizumabIntravitreal ranibizumabmedicine.symptombusinessTomography Optical Coherencemedicine.drugActa Ophthalmologica
researchProduct